Clinical trial: FICTIoN Cohort
FICTIoN Cohort: Radiomic analyses of 18FDG PET and correlation with histology
Type of study: Single-centre study
Pathology: Triple-negative breast cancer, operated on or undergoing adjuvant chemotherapy
Investigator: Dr. Caroline Rousseau
NCT number : NCT04226222
The main objective of this FICTIoN cohort is to evaluate the prognostic value of FDG PET texture parameters on 2-year event-free survival (EFS). These texture parameters will be correlated with an immunohistological analysis.
This research programme could eventually lead to the availability of a non-invasive test (texture analysis on FDG PET) alone or combined with immunohistochemistry results that are not currently performed routinely, which would make it possible to assess tumour aggressiveness and contribute to personalising the treatment of triple-negative breast cancers